RT Book, Section
A1 Slattery, David E.
A1 Pollack, Jr, Charles V.
A2 Tintinalli, Judith E.
A2 Ma, O. John
A2 Yealy, Donald M.
A2 Meckler, Garth D.
A2 Stapczynski, J. Stephan
A2 Cline, David M.
A2 Thomas, Stephen H.
SR Print(0)
ID 1166813100
T1 Thrombotics and Antithrombotics
T2 Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260019933
LK accessemergencymedicine.mhmedical.com/content.aspx?aid=1166813100
RD 2024/04/19
AB Antithrombotic  therapy  (i.e.,  anticoagulants,  antiplatelet  agents,  and  fibrinolytics)  is  used  to  treat  or  reduce  the  risk  of  arterial  and  venous  thromboembolic  conditions,  including  acute  coronary  syndrome,  deep  venous  thrombosis  and  pulmonary  embolism  (collectively,  venous  thromboembolic  disease),  transient  ischemic  attack,  and  ischemic  stroke  (Table  239-1).  Moreover,  antithrombotic  agents  help  prevent  occlusive  vascular  events  in  patients  at  risk  for  thrombosis  due  to  atherosclerotic  arterial  disease,  atrial  fibrillation,  medical  illness  with  immobility,  or  surgical  insult.  These  agents,  however,  can  cause  life-threatening  complications,  primarily  serious  or  life-threatening  hemorrhage.  Detailed  management  strategies  for  thromboembolic  disorders  are  discussed  in  their  respective  chapters  (see  Chapter  49,  “Acute  Coronary  Syndromes”;  Chapter  56,  “Venous  Thromboembolism  Including  Pulmonary  Embolism”;  and  Chapter  167,  “Stroke  Syndromes”).